Status:
RECRUITING
Impact of Peripheral Vascular Stiffness Assessment on Risk Prediction in Patients With Myocardial Infarction
Lead Sponsor:
University Hospital, Lille
Collaborating Sponsors:
Fédération Française de Cardiologie
Merck Sharp & Dohme LLC
Conditions:
Myocardial Infarction
Vascular Stiffness
Eligibility:
All Genders
18+ years
Brief Summary
Risk assessment after myocardial infarction is critical in daily practice and evolution toward heart failure especially diastolic heart failure remains a key issue. All consecutive patients with myoca...
Eligibility Criteria
Inclusion
- Signed informed consent
- Affiliated to national health insurance (French social security number)
- Presenting with MI within 48 hours of symptom onset
Exclusion
- Patient under curatorship
- Type 2 MI
- Presenting with MI after 48 hours of symptom onset
- Pregnancy or lactating
- Refuse to participate
- No national health insurance (No French social security number)
Key Trial Info
Start Date :
February 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04058782
Start Date
February 17 2020
End Date
March 1 2030
Last Update
March 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Coeur-Poumon, CHU
Lille, France, 59037